Please use this identifier to cite or link to this item:
https://apo.ansto.gov.au/dspace/handle/10238/2847| Title: | Cell labeling: tracking, viability and function |
| Authors: | Smith, SV |
| Keywords: | Stem cells Neoplasms Regulations Diseases Therapy Commercialization |
| Issue Date: | 1-Dec-2005 |
| Publisher: | Edizioni Minerva Medica |
| Citation: | Smith, S. V. (2005). Cell labeling: tracking, viability and function. Quarterly Journal of Nuclear Medicine and Molecular Imaging, 49(4), 301-303. |
| Abstract: | The rapid progress in research of cell therapy for Parkinson's and Alzheimer's disease, cardiology and cancer has raised considerable excitement and controversy in recent times. In countries such as the UK, Sweden, Singapore, Korea, Japan and Australia, public dicussion has helped to clarify the regulatory framework for their stem cell research. Unfortunately the controversy continues in the US and is expected to significantly impact on the commercialization of much of this technology. © 2005, Edizioni Minerva Medica |
| Gov't Doc #: | 3047 |
| URI: | http://www.minervamedica.it/en/journals/nuclear-med-molecular-imaging/article.php?cod=R39Y2005N04A0301 http://apo.ansto.gov.au/dspace/handle/10238/2847 |
| ISSN: | 1824-4661 |
| Appears in Collections: | Journal Articles |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.